MOTS-c and weight loss: what the studies really say
MOTS-c is often touted as a "fat-burning" peptide. The reality is more interesting: it affects how muscles use sugar and energy. Here's what studies have measured regarding weight and insulin levels, in both animals and humans, and what distinguishes it from weight-loss molecules.
MOTS-c 40 mg – €99.90The complete guide
In mice: the seminal study
In the 2015 study that popularized MOTS-c (Lee et al., Cell Metabolism), mice were fed a very high-fat diet. Those treated with MOTS-c avoided the weight gain and insulin resistance observed in the others, without eating less. The peptide increased glucose uptake by muscles and energy expenditure.
Insulin sensitivity
The core effect of MOTS-c is metabolic: by activating AMPK in muscle, it promotes glucose uptake by cells, similar to exercise. In the same study, it also reversed age-related decline in insulin sensitivity in mice. This is why it is primarily studied as a metabolic regulator, rather than as an appetite suppressant.
In humans
- Observational studies Several studies have measured lower MOTS-c levels in overweight, insulin-resistant, or diabetic individuals. This demonstrates an association, not an effect of the peptide.
- CB4211 Analog This MOTS-c analogue was tested in phase 1 in obese individuals with hepatic steatosis. It was well tolerated, with signals on liver markers and blood glucose levels over a short period.
- To date, no weight loss studies have been published with MOTS-c itself.
MOTS-c or retatrutide: two approaches
| MOTS-c | Retatrutide | |
|---|---|---|
| Target | AMPK in muscle (exercise pathway) | GLP-1, GIP and glucagon receptors |
| Appetite | No appetite-suppressant effect described | Greatly reduced |
| Human data | Measurements and a phase 1 analogue | Up to -24.2% of weight in 48 weeks (phase 2) |
| MyPeptide price | 40 mg: €99.90 | 10 mg: €59.90 |
Many laboratories studying retatrutide are also interested in MOTS-c, as they affect two different aspects of metabolism. No studies have linked them. For another molecule studied for its effect on fat, see retatrutide vs tesamorelin.
The limits
- The effects on weight come from studies in mice.
- In humans, only phase 1 measurements and an analogue are available.
- MOTS-c is not authorized anywhere: it is a research peptide.
Price
Lyophilized vials: €4.99/mg for 10 mg, €2.50/mg for 40 mg. Batch 40 mg analyzed by Janoshik: 99.553% purity, 44.07 mg measured. Shipping from the European Union in 2 to 5 business days; delivery €10, free from €160.
MOTS-c 40 mg – €99.90MOTS-c 10 mg – €49.90
- MOTS-c: The Complete Guide
- MOTS-c and sport
- Side effects and reviews
- MOTS-c or SS-31
- Our Janoshik (COA) analysis
- The science of MOTS-c (article)
Frequently asked questions
Does MOTS-c cause weight loss?
In mice fed a high-fat diet, it prevented weight gain and insulin resistance. In humans, no weight loss trials have been published with MOTS-c itself.
Is MOTS-c an appetite suppressant?
No, no appetite-suppressant effect has been described: it acts on the use of glucose and energy by the muscles, via the AMPK pathway.
Does MOTS-c improve insulin sensitivity?
In mice, yes: it corrected insulin resistance linked to a high-fat diet and age. In humans, low levels have been associated with insulin resistance.
MOTS-c or retatrutide: what's the difference?
Retatrutide acts on appetite and energy expenditure via GLP-1, GIP and glucagon receptors; MOTS-c acts on muscle metabolism via AMPK, without an appetite-suppressant effect.
What is the price of the MOTS-c?
At MyPeptide, €49.90 for a 10 mg vial and €99.90 for a 40 mg vial, i.e. €2.50/mg.
Sources: Lee C. et al., Cell Metabolism 2015; Jastreboff A.M. et al., N Engl J Med 2023; CohBar communications on CB4211 (phase 1). MyPeptide products are intended exclusively for scientific laboratory research.
